Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
Holders of 5% or more of LHDX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Lucira Health, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Lucira Health, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Lucira Health, Inc., newest first.
No Schedule 13D or 13G filings on Lucira Health, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Lucira Health, Inc. shares.
No Form 144 notices for Lucira Health, Inc. are on file.